Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis.
Hee-Young YoonSojung ParkDong Soon KimJin Woo SongPublished in: Respiratory research (2018)
The efficacy and safety profiles of nintedanib in the advanced group were comparable to those in the non-advanced group except for a higher frequency of discontinuation, which may be due to the advanced status itself.